News
A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of ...
Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback